Bioinformatics-Driven Engineering of ROS-Responsive Dextran-block-Poly(propylene sulfide) Nanoparticles Functionalized with Folic Acid for Targeted Prostate Cancer Therapy
Open Access
- 4 June 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (23) , 24601-24617
Abstract
Prostate cancer (PCa) remains a significant challenge in oncology due to its complex pathogenesis and resistance to conventional therapies. By leveraging bioinformatics-guided insights, we identified folate hydrolase 1 (FOLH1) as a crucial biomarker with overexpression in various cancers, particularly PCa. Therefore, we prepared folate receptor-targeted reactive oxygen species (ROS)-responsive dextran-block-poly(propylene sulfide) nanoparticles to enhance targeted therapeutic efficacy against PCa. The block copolymer was achieved using Cu(I)-catalyzed “click” chemistry, followed by the successful conjugation of folic acid (FA). Characterization confirmed the nanoparticles’ ability to encapsulate doxorubicin (Dox) and respond to ROS, releasing the drug under oxidative conditions. In vitro studies demonstrated enhanced cellular uptake, increased ROS production, and superior cytotoxicity of FA-Dex-b-PPS-Dox in PC3 cells compared to free Dox and nontargeted Dex-b-PPS-Dox nanoparticles. Furthermore, FA-Dex-b-PPS-Dox significantly inhibited tumor cell migration and invasion, emphasizing its potential for comprehensive cancer therapy. In vivo efficacy was assessed using a PC3 tumor model, where FA-Dex-b-PPS-Dox notably reduced tumor volume and weight, with histological analyses confirming enhanced apoptosis and reduced cell proliferation. These findings underscore the promising potential of FA-Dex-b-PPS-Dox in providing a targeted, ROS-responsive therapeutic strategy for prostate cancer.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515012160, 2023A1515012320, 2024A1515010477)
- Guangzhou Municipal Science and Technology Bureau (2023A03J0969)
- Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia (0031/2021/A, 0090/2022/A)
- National Natural Science Foundation of China (82072813, 82272276, 82373166)
This publication has 42 references indexed in Scilit:
- Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEGChemMedChem, 2023
- Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapyColloids and Surfaces B: Biointerfaces, 2023
- Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer TreatmentAdvanced Materials, 2023
- Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapyActa Biomaterialia, 2021
- Block copolymers containing dextran and deoxycholic acid polyesters. Synthesis, self-assembly and hydrophobic drug encapsulationCarbohydrate Polymers, 2019
- Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in miceBiomaterials, 2017
- Stability of Drugs, Drug Candidates, and Metabolites in Blood and PlasmaCurrent Protocols in Pharmacology, 2016
- Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeuticBiomaterials, 2016
- ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial diseaseBiomaterials, 2015
- Polysaccharide‐block‐polypeptide Copolymer Vesicles: Towards Synthetic Viral CapsidsAngewandte Chemie International Edition, 2009